TIN-ACT: Tinnitus Assessment, Causes and Treatments
TIN-ACT is a European consortium that investigates tinnitus (“ringing in the ears”). Tinnitus is a very common and potentially devastating condition. People with tinnitus continuously hear a penetrating phantom sound in absence of actual sound. An estimated 50.8 million EU citizens hear tinnitus, of which 5.1 million are severely bothered by it. Tinnitus can be enormously debilitating and leads to difficulty concentrating, lack of sleep, anxiety, and depression. Even mild forms of tinnitus reduce productivity due to difficulty hearing and concentrating at work and also resting and relaxing during leisure time. In order to cure tinnitus, we need to bridge the gap between basic fundamental research, applied clinical research and product development. Our aim is to understand the basic neural mechanisms of tinnitus, and to find ways to measure and treat tinnitus.
Management
Network coordinator: Pim van Dijk
Training coordinator: Sonja Pyott
Program manager: Elouise Koops
Work package leaders: UMCG (1,6), Oticon (2), Erlangen (3), Widex (4), CNRS (5).
External Advisory Board
Prof. Barbara Canlon – Karonlinska Institute
Prof. Jos Eggermont – University of Calgary
